We are live on
!
Find out more
AA
AlphaCentric Advisors Portfolio holdings
AUM
$100M
This Fund
S&P 500
This Quarter
Est. Return
+7.21%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$166M
AUM Growth
+$16.8M
(+11%)
Cap. Flow
+$19.2M
Cap. Flow
% of AUM
11.58%
Top 10 Holdings %
Top 10 Hldgs %
22.19%
Holding
254
New
38
Increased
43
Reduced
118
Closed
26
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
United Therapeutics
UTHR
|
+$3.61M |
| 2 |
NARI
Inari Medical, Inc. Common Stock
NARI
|
+$3.1M |
| 3 |
Axsome Therapeutics
AXSM
|
+$2.73M |
| 4 |
Pfizer
PFE
|
+$2.64M |
| 5 |
TRML
Tourmaline Bio
TRML
|
+$2.15M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IMGN
Immunogen Inc
IMGN
|
+$3.78M |
| 2 |
WBA
Walgreens Boots Alliance
WBA
|
+$3.13M |
| 3 |
ABVX
Abivax
ABVX
|
+$2.86M |
| 4 |
Ironwood Pharmaceuticals
IRWD
|
+$2.8M |
| 5 |
Amylyx Pharmaceuticals
AMLX
|
+$2.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 61.45% |
| 2 | Real Estate | 11.2% |
| 3 | Financials | 4.6% |
| 4 | Industrials | 3.92% |
| 5 | Technology | 2.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
PACCAR
PCAR
$66.1B
| $514K | 0.31% |
4,146
-472
| -10% | -$50.7K |
|
77
JPMorgan BetaBuilders Japan ETF
BBJP
$17.2B
| $512K | 0.31% |
8,747
-798
| -8% | -$44.3K |
|
78
iShares MSCI Australia ETF
EWA
$1.34B
| $510K | 0.31% |
20,694
+506
| +3% | +$12.1K |
|
79
Cardinal Health
CAH
$53.1B
| $509K | 0.31% |
4,546
-507
| -10% | -$54.7K |
|
80
Invesco QQQ Trust
QQQ
$468B
| $501K | 0.3% |
1,128
-3,994
| -78% | -$1.71M |
|
81
Invesco NASDAQ 100 ETF
QQQM
$97.8B
| $501K | 0.3% |
2,740
-9,738
| -78% | -$1.72M |
|
|
VALN
82
Valneva
VALN
$503M
| $495K | 0.3% |
62,004
+27,706
| +81% | +$226K |
|
83
Nuvation Bio
NUVB
$2.21B
| $491K | 0.3% |
135,000
-315,000
| -70% | -$605K |
|
84
iShares MBS ETF
MBB
$39.2B
| $462K | 0.28% |
+5,000
| New | +$462K |
|
85
iShares 1-3 Year Treasury Bond ETF
SHY
$25.4B
| $446K | 0.27% |
5,458
-5,882
| -52% | -$481K |
|
86
Aurinia Pharmaceuticals
AUPH
$1.98B
| $401K | 0.24% |
80,000
+30,000
| +60% | +$204K |
|
|
COOP
87
DELISTED
Mr. Cooper
COOP
| $384K | 0.23% |
4,931
-16,660
| -77% | -$1.16M |
|
88
Delta Air Lines
DAL
$55.6B
| $380K | 0.23% |
7,932
-1,059
| -12% | -$43.8K |
|
89
Pultegroup
PHM
$23.5B
| $378K | 0.23% |
3,132
-421
| -12% | -$45.2K |
|
90
iShares 3-7 Year Treasury Bond ETF
IEI
$18.2B
| $375K | 0.23% |
3,242
-1,326
| -29% | -$154K |
|
91
Vanguard High Dividend Yield ETF
VYM
$80.1B
| $374K | 0.23% |
3,088
-270
| -8% | -$30.9K |
|
92
iShares Mortgage Real Estate ETF
REM
$554M
| $371K | 0.22% |
15,954
+177
| +1% | +$4.01K |
|
93
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.7B
| $363K | 0.22% |
4,972
-270
| -5% | -$19.3K |
|
94
State Street SPDR S&P International Dividend ETF
DWX
$524M
| $363K | 0.22% |
10,316
-101
| -1% | -$3.54K |
|
95
Invesco S&P 500 BuyWrite ETF
PBP
$353M
| $363K | 0.22% |
16,127
-592
| -4% | -$13K |
|
96
iShares JPMorgan EM High Yield Bond ETF
EMHY
$622M
| $362K | 0.22% |
9,669
-483
| -5% | -$17.6K |
|
97
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
| $362K | 0.22% |
4,036
-138
| -3% | -$12.2K |
|
98
iShares Preferred and Income Securities ETF
PFF
$13.3B
| $357K | 0.22% |
11,075
-616
| -5% | -$19.6K |
|
99
Invesco Senior Loan ETF
BKLN
$7.1B
| $357K | 0.22% |
16,875
-276
| -2% | -$5.83K |
|
100
United Airlines
UAL
$38.3B
| $327K | 0.2% |
6,828
-930
| -12% | -$39.9K |
|
Similar funds
WCM
FCM
BIA
AGAM
E
HCM
AC
OIS
AlphaCentric Advisors's Q1 2024 Portfolio in Review
As of Q1 2024, AlphaCentric Advisors held 254 positions worth $166M, up 11% from $149M the previous quarter. Its ten largest holdings account for 22% of the portfolio.
AlphaCentric Advisors deployed $19.2M of net new capital in Q1 2024, opening 38 new positions and adding to 43 existing holdings. Its largest new stake was United Therapeutics: 16,000 shares worth $3.68M.
By sector, the portfolio is most concentrated in Healthcare at 61% of assets, up from 59% a quarter earlier, followed by Real Estate and Financials.
On the sell side, the largest reduction was Invesco NASDAQ 100 ETF, an estimated $1.72M trimmed.
- AlphaCentric Advisors's largest Q1 2024 buy was United Therapeutics: 16,000 shares worth $3.68M.
- AlphaCentric Advisors added most to Inari Medical, Inc. Common Stock in Q1 2024, an estimated $3.1M increase.
- AlphaCentric Advisors's biggest Q1 2024 reduction was Invesco NASDAQ 100 ETF, cutting an estimated $1.72M.
- AlphaCentric Advisors fully exited Immunogen Inc in Q1 2024, selling an estimated $3.78M.
- AlphaCentric Advisors's ten largest holdings make up 22% of its $166M portfolio in Q1 2024.
- AlphaCentric Advisors opened 38 new positions and closed 26 in Q1 2024.
- AlphaCentric Advisors's portfolio value rose 11% quarter-over-quarter to $166M.
Based on AlphaCentric Advisors's 13F filing for Q1 2024, filed 24 Apr 2024.